M. Lunde

1.1k citations

28 papers · 762 indexed · h-index 14

Impact in

Biological Psychiatry top 5%
- Tryptophan and brain disorders
Endocrine and Autonomic Systems top 5%
- Circadian rhythm and melatonin

Papers in ⓘ

Pharmacology 11
- Treatment of Major Depression 11
Experimental and Cognitive Psychology 11
- Mental Health Research Topics 10
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 4

Co-authors: Per Bech (20 shared papers)Klaus Martiny (10 shared papers)M Undén (6 shared papers)Nina Timmerby (1 shared paper)Lotte Lauritzen (8 shared papers)Lone Lindberg (3 shared papers)Henrik Dam (4 shared papers)L. Clemmesen (4 shared papers)
Journals: Acta Psychiatrica Scandinavica (8 papers)Pharmacopsychiatry (4 papers)European Neuropsychopharmacology (2 papers)BMC Psychiatry (1 paper)Journal of Affective Disorders (1 paper)
Partner nations: Denmark United States Sweden

In The Last Decade

M. Lunde

27 papers receiving 739 citations

Peers

Replace Ornah T. Dolberg with:

Ornah T. Dolberg Israel

Charles F. Reynolds United States

Shi-Bin Wang Australia

Louisa Norrie Australia

Natalie St. Cyr United States

Milos Milic United States

Joseph A. Kwentus United States

Marie Anne Gebara United States

Doron Todder Israel

S. Woodring United States

M. Lunde relative to Ornah T. Dolberg Israel Ornah T. Dolberg's profile →

Citations per field

00.5×2×3×

Ornah T. Dolberg · 1×

×1.0 71/69

BP

×1.0 139/140

EAS

×0.4 129/343

NEURO

×0.7 234/359

PMH

×0.5 189/386

ECP

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Countries citing papers authored by M. Lunde

Since Specialization

Citations

This map shows the geographic impact of M. Lunde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lunde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lunde more than expected).

Fields of papers citing papers by M. Lunde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Lunde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lunde. The network helps show where M. Lunde may publish in the future.

Co-authors

The 25 scholars most cited alongside M. Lunde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Lunde Line = papers co-authored together M. Lunde links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Psychometric evaluation of the Major Depression Inventory (MDI) as depression severity scale using the LEAD (Longitudinal Expert Assessment of All Data) as index of validity BMC Psychiatry ·Per Bech, Nina Timmerby, Klaus Martiny, M. Lunde, Susan Soendergaard	2015	161
2	Repetitive Transcranial Magnetic Stimulation (rTMS) in Combination with Escitalopram in Patients with Treatment-Resistant Major Depression. A Double-Blind, Randomised, Sham-Controlled Trial Pharmacopsychiatry ·L. Bretlau, M. Lunde, Lone Lindberg, M Undén, Steen Dissing, Per Bech	2008	76
3	Relapse prevention by means of paroxetine in ECT‐treated patients with major depression: a comparison with imipramine and placebo in medium‐term continuation therapy Acta Psychiatrica Scandinavica ·Lotte Lauritzen, K. Odgaard, L. Clemmesen, M. Lunde, Jan K. Öhrström, Corri Black, Per Bech	1996	74
4	Adjunctive bright light in non‐seasonal major depression: results from clinician‐rated depression scales Acta Psychiatrica Scandinavica ·Klaus Martiny, M. Lunde, M Undén, Henrik Dam, Per Bech	2005	67
5	Post-stroke depression: combined treatment with imipramine or desipramine and mianserin Psychopharmacology ·Lotte Lauritzen, Birgitte Bjerg Bendsen, T. Vilmar, E. Bjerg Bendsen, M. Lunde, Per Bech	1994	59
6	Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo‐controlled study Acta Psychiatrica Scandinavica ·Klaus Martiny, M. Lunde, Christian Simonsen, Lars Clemmensen, Dorte Loldrup Poulsen, Kim Solstad, Per Bech	2004	41
7	A validation analysis of two self‐reported HAM‐D₆ versions Acta Psychiatrica Scandinavica ·Per Bech, Peter H. Wilson, Thomas Wessel, M. Lunde, Maurizio Fava	2008	38
8	Psychiatric outcome studies (POS): Does treatment help the patients? A Popperian approach to research in clinical psychiatry Nordic Journal of Psychiatry ·Per Bech, M. Lunde, G. Bech-Andersen, Lone Lindberg, Klaus Martiny	2007	37
9	Maintained superiority of chronotherapeutics vs. exercise in a 20-week randomized follow-up trial in major depression Acta Psychiatrica Scandinavica ·Klaus Martiny, Else Refsgaard, Vibeke Lund, M. Lunde, Britta Thougaard, Lone Lindberg, Per Bech	2015	28
10	Adjunctive bright light in non‐seasonal major depression: results from patient‐reported symptom and well‐being scales Acta Psychiatrica Scandinavica ·Klaus Martiny, M. Lunde, M Undén, Henrik Dam, Per Bech	2005	28
11	Combined Treatment with Imipramine and Mianserin Pharmacopsychiatry ·Lotte Lauritzen, L. Clemmesen, R. Klysner, D. Loldrup, M. Lunde, E. Schaumburg, S. Waarst, Per Bech	1992	28
12	Social Adaptation Self-evaluation Scale (SASS): Psychometric analysis as outcome measure in the treatment of patients with major depression in the remission phase International Journal of Psychiatry in Clinical Practice ·Per Bech, M. Lunde, M Undén	2002	19
13	A double-blind placebo-controlled study of sertraline in the prevention of depression in stroke patients European Neuropsychopharmacology ·A. Rasmussen, M. Lunde, K. Sørensen, S Qvitzau, Per Bech	2002	15
14	The Validity of the Depression Rating Scales in Discriminating between Citalopram and Placebo in Depression Recurrence in the Maintenance Therapy of Elderly Unipolar Patients with Major Depression Pharmacopsychiatry ·Jesper Bent-Hansen, M. Lunde, R. Klysner, Mikkel Østerheden Andersen, P. Tanghøj, Kim Solstad, Per Bech	2003	13
15	High cortisol awakening response is associated with an impairment of the effect of bright light therapy Acta Psychiatrica Scandinavica ·Klaus Martiny, M. Lunde, M Undén, Henrik Dam, Per Bech	2009	13
16	The Pharmacopsychometric Triangle to Illustrate the Effectiveness of T-PEMF Concomitant with Antidepressants in Treatment Resistant Patients: A Double-Blind, Randomised, Sham-Controlled Trial Revisited with Focus on the Patient-Reported Outcomes SHILAP Revista de lepidopterología ·Per Bech, Maria Gefke, M. Lunde, Lotte Lauritzen, Klaus Martiny	2011	13
17	A definite and a semidefinite questionnaire version of the Hamilton/melancholia (HDS/MES) scale Journal of Affective Disorders ·Jesper Bent-Hansen, Lotte Lauritzen, L. Clemmesen, M. Lunde, A. Kørner	1995	9
18	Platelet serotonin transporter in stroke patients Acta Neurologica Scandinavica ·Annette Rasmussen, Jon M. Christensen, Peter Clemmensen, Niels Joern Dalsgaard, Henrik Dam, I. Hindberg, M. Lunde, Per Plenge, Erling T. Mellerup	2003	9
19	Identifying Patients with Therapy-Resistant Depression by using Factor Analysis Pharmacopsychiatry ·Kalle Andreasson, V. Liest, M. Lunde, Klaus Martiny, M Undén, Steen Dissing, Per Bech	2010	8
20	Platelet paroxetine binding in alcoholics European Neuropsychopharmacology ·Erling T. Mellerup, Per Bech, Lotte Lauritzen, M. Lunde, Per Plenge	1992	8

About M. Lunde

M. Lunde is a scholar working on Pharmacology, Experimental and Cognitive Psychology, Psychiatry and Mental health, Endocrine and Autonomic Systems and Biological Psychiatry, having authored 28 papers that have together received 762 indexed citations. Recurring topics across this work include Treatment of Major Depression (11 papers), Mental Health Research Topics (10 papers), Circadian rhythm and melatonin (6 papers), Electroconvulsive Therapy Studies (5 papers), Tryptophan and brain disorders (4 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Transcranial Magnetic Stimulation Studies (2 papers) and Bipolar Disorder and Treatment (2 papers). The work is most often cited by research in Biological Psychiatry (71 citations), Endocrine and Autonomic Systems (139 citations), Neurology (129 citations), Psychiatry and Mental health (234 citations) and Experimental and Cognitive Psychology (189 citations). M. Lunde has collaborated with scholars based in Denmark, United States and Sweden. Frequent co-authors include Per Bech, Klaus Martiny, M Undén, Nina Timmerby, Lotte Lauritzen, Lone Lindberg, Henrik Dam, L. Clemmesen, Steen Dissing and Jan K. Öhrström. Their work appears in journals such as Acta Psychiatrica Scandinavica, Pharmacopsychiatry, European Neuropsychopharmacology, BMC Psychiatry and Journal of Affective Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact